In-home HEPA filtration to slow biological aging and improve heart and lung health in older adults with eosinophilic COPD
Official title: Impact of an Air Purification Intervention on Biological Aging and Molecular Signatures of Improved Cardiometabolic Health in High-Risk Older Adults
Funded at Stanford University · NIH-11390736 · Data updated 2026-11-12
A 12-month in-home HEPA filter trial in older adults with eosinophilic COPD examines whether cleaner indoor air can slow aging markers and improve heart and lung health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | August 13, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $850,689 |
| NIH project number | 1R01ES038763-01 |
| Project ID | NIH-11390736 on NIH RePORTER |
Who could benefit from this research
✓Could help
Older adults (21+ years) with eosinophilic COPD who smoke or have a history of smoking and live in homes where HEPA filtration could be implemented.
✕Less likely to help
Individuals without eosinophilic COPD or without environmental exposure to indoor particulates may not experience the same biological or clinical benefits.
What this research studies
This study builds on a randomized, double-blind trial that places HEPA filters or sham devices in homes of former smokers with eosinophilic COPD for one year. Researchers will measure aging-related molecular changes in nasal tissue and blood, along with cardiopulmonary health indicators, to see if cleaner air slows aging at a biological level. The approach combines epigenetic and proteomic analyses with clinical assessments to understand how reducing indoor particulate exposure affects aging and disease risk in a high-risk population. Participants will continue to receive follow-up visits and sample collection as part of the parent trial at NIEHS. Overall, the project seeks to link real-world air quality improvements to tangible biological and health benefits for older adults with COPD.
Why it matters
Potential benefit: If successful, participants could experience slower biological aging signals and improved heart and lung health from a simple air-cleaning intervention.
How similar studies have gone: Previous studies link air purification to reduced pollutant exposure; this study uniquely tests causal effects on molecular aging markers in a high-risk human population.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Cardenas, Andres — Stanford University
- Study coordinator: Cardenas, Andres
Related research
Other NIH-funded projects on the same topics.
-
How estrogen and heart/metabolic health affect memory in aging women
This project is seeing if estrogen treatment protects thinking and memory in older women and whether conditions like diabetes or high blood pressure change that effect.
-
The effects of estrogens on brain health and aging in women.
This study is looking at how menopause might raise the risk of Alzheimer's and whether estrogen therapy can help protect brain health, especially for women with different heart and metabolic health issues.
-
Aging Well with HIV: Alcohol, Risk Reduction, and Education Center (AWAR3E)
A center at Yale is exploring how aging with HIV interacts with alcohol use to create inflammation and frailty, with the goal of finding biomarkers and potential treatments.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
Biological aging across the lifespan through a national high school-to-adult study
This grant uses a long-running national study of students and adults to collect saliva biomarkers of aging, alongside surveys, to understand how aging markers relate to health and life experiences.
-
Understanding how aging and Alzheimer’s affect how people make tough choices
This NIH grant studies how aging and Alzheimer’s risk change how people decide between immediate and delayed rewards and risky options, with the goal of helping older adults stay financially and healthwise safer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.